9
Participants
Start Date
July 31, 2012
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
BI 135585 XX
one single dose
1283.34.1 Boehringer Ingelheim Investigational Site, Neuss
Lead Sponsor
Boehringer Ingelheim
INDUSTRY